Hi All,
Does anybody know whether the results of the Phase II Ambroxol clinical trial, conducted in the University College, London, and completed about half a year ago, are publicly available? (Ambroxol is a repurposed drug which is expected to help PD patients with the GBA mutation.)
Thanks!